Persistent increase of carbohydrate antigen 19‐9 with an unknown reason: A seven‐year follow‐up case - Zhao - 2022 - Journal of Clinical Laboratory Analysis - Wiley Online Library
Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis | SpringerLink
Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer
False-positive rates of CEA according to level (N=597) | Download Scientific Diagram
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
CA19-9 - Wikipedia
![PDF] False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1144a56968788915c60eb298e39fcf2d60c86823/5-Table2-1.png "PDF] False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. | Semantic Scholar")
PDF] False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. | Semantic Scholar
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
Tumor Marker:- Part 7 - CA 125 and CA 19-9 - Labpedia.net
Common benign HPB conditions with associated deranged CA19.9 level | Download Table
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
Leise Präambel Vulkanisch туморни маркери ca 19 9 Sparen Schäbig Tansania
Persistent elevation of Ca 19-9 and an unexpected finding. A case report | Cirugía y Cirujanos (English Edition)
Tumor markers in pancreatic cancer: 2013. | Semantic Scholar
Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas | BMC Cancer | Full Text
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection - ScienceDirect
Table 1 from Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar
Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder Bind MK, Mishra RR, Kumar V, Misra V, Singh PA - Indian J Pathol Microbiol
Non-malignant causes of CA19.9 elevation (medline research) | Download Table
IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite
Cancers | Free Full-Text | Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer
Cureus | Infection Masquerading as Recurrence of Pancreatic Ductal Adenocarcinoma: A Cautionary Tale | Article
Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA | BMC Medicine | Full Text
